Published on: August 12, 2020 at 09:30PM
Conditions: Coronavirus Infection; Diabetes Mellitus, Type 2
Interventions: Drug: Canakinumab; Drug: Placebo
Sponsors: University Hospital, Basel, Switzerland; Novartis; Swiss National Science Foundation
Not yet recruiting
https://ift.tt/3gQZErQ
Wednesday, 12 August 2020
New diabetes clinical trial: Canakinumab in Patients With COVID-19 and Type 2 Diabetes
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Nothing happens without a Reason
Make Something out of it.